Semaglutide and tirzepatide were associated with better hospitalization and mortality outcomes than sitagliptin in HFpEF and type 2 diabetes.
Background Is being famous a risk factor for premature death? Previous studies indicate that famous musicians have a higher ...
Objective To develop prediction models for short-term outcomes following a first acute myocardial infarction (AMI) event (index) or for past AMI events (prevalent) in a national primary care cohort.
XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...
Braze (Nasdaq: BRZE), the leading customer engagement platform that empowers brands to Be Absolutely Engaging™, today ...
Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...
Discusses Positive Topline Results From DELIVER Registrational Expansion Cohort in Duchenne Muscular Dystrophy December ...
Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...
The Healthy @Reader's Digest on MSN
This is the ideal blood pressure that prevents heart disease, says new study
Blood pressure guidelines vary from country to country, but new insights from Korea reinforce a universal systolic blood ...
Researchers found a bidirectional link between type 2 diabetes and IBD, with each condition increasing the risk for incident onset of the other.
A research team found an association between cannabis use and reduced risk of oral cancer. Previous studies have reported ...
On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) finalized the Ambulatory Specialty Model (ASM) in the CY 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback